Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    1710777 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Use of Warmed Saline in Vaso-occlusive Episodes
Conditions: Sickle Cell Disease;   Sickle Cell Crisis
Intervention: Device: Astoflo Plus fluid warmer
2 Completed Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
Conditions: Sickle Cell Disease;   Chronic Kidney Disease;   Pulmonary Hypertension
Intervention: Drug: Erythropoietin and Hydroxyurea
3 Recruiting Blood Flow and Pain Crises in People With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention:
4 Completed Cooperative Study of The Clinical Course of Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Blood Disease
Intervention:
5 Recruiting Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Conditions: Sickle Cell Disease;   Hb-SS Disease With Vasoocclusive Pain;   Hemoglobin SS Disease With Vasoocclusive Crisis;   Other Sickle Cell Disease With Vaso-Occlusive Pain;   Hemoglobin SS Disease With Crisis
Interventions: Drug: Abciximab;   Drug: Placebo;   Other: Intravenous hydration;   Drug: Ibuprofen;   Drug: Parenteral narcotic;   Other: Incentive spirometry;   Other: Supplemental oxygen

Indicates status has not been verified in more than two years